Trademark: 90324264
Status Date
Monday, August 21, 2023
Filing Date
Tuesday, November 17, 2020
Published for Opposition
Tuesday, May 25, 2021
Abandoned Date
Monday, August 21, 2023
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Aug 21, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 21, 2023
Abandonment - No Use Statement Filed
Dec 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 14, 2022
Sou Extension 3 Granted
Dec 14, 2022
Sou Extension 3 Filed
Dec 14, 2022
Sou Teas Extension Received
Dec 5, 2022
Teas Change Of Correspondence Received
Dec 5, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 5, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 5, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 14, 2022
Sou Extension 2 Granted
Jun 14, 2022
Sou Extension 2 Filed
Jun 14, 2022
Sou Teas Extension Received
Dec 15, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 13, 2021
Sou Extension 1 Granted
Dec 13, 2021
Sou Extension 1 Filed
Dec 13, 2021
Sou Teas Extension Received
Jul 20, 2021
Noa E-Mailed - Sou Required From Applicant
May 25, 2021
Official Gazette Publication Confirmation E-Mailed
May 25, 2021
Published For Opposition
May 5, 2021
Notification Of Notice Of Publication E-Mailed
Apr 22, 2021
Approved For Pub - Principal Register
Apr 21, 2021
Assigned To Examiner
Jan 16, 2021
New Application Office Supplied Data Entered
Nov 20, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
